Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» cystic fibrosis
cystic fibrosis
‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress
‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress
Stat
cystic fibrosis
drug development
patients
Flag link:
Cystic fibrosis patients lobby Vertex to drop drug prices
Cystic fibrosis patients lobby Vertex to drop drug prices
Pharmaforum
Vertex Pharmaceuticals
cystic fibrosis
drug pricing
patients
Flag link:
Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates
Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates
CP Wire
Talee Bio
cystic fibrosis
TL-101
TL-102
Flag link:
Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates
Talee Bio
cystic fibrosis
TL-101
TL-102
Flag link:
European Commission Approves Kalydeco to Treat Cystic Fibrosis
European Commission Approves Kalydeco to Treat Cystic Fibrosis
CP Wire
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Europe
Flag link:
European Commission Approves Kalydeco to Treat Cystic Fibrosis
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials
Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials
Stat
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-659 + tezacaftor + ivacaftor
Flag link:
Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval
Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval
EP Vantage
Vertex Pharma
cystic fibrosis
Symdeko
Kalydeco
Global Blood Therapeutics
voxelotor
sickle cell disease
Flag link:
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
Motley Fool
AbbVie
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
AbbVie Takes Over Galapagos Cystic Fibrosis Collaboration Instead of Walking Away
BioSpace
AbbVie
Galapagos
cystic fibrosis
Flag link:
Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis
Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis
CP Wire
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation
Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation
CP Wire
Synspira
FDA
SNSP113
cystic fibrosis
Flag link:
Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation
Synspira
cystic fibrosis
SNSP113
Flag link:
Vivus, diving into the cystic fibrosis sphere, backs stadium step-climbing fundraiser
Vivus, diving into the cystic fibrosis sphere, backs stadium step-climbing fundraiser
Fierce Pharma
Vivus
cystic fibrosis
Pancreaze
Flag link:
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
Mylan Strikes $463 Million Deal With Novartis for CF Product Line
BioSpace
Mylan Labs
Novartis
cystic fibrosis
Flag link:
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
CP Wire
Vertex Pharmaceuticals
VX-659
VX-445
correctors
cystic fibrosis
Flag link:
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Vertex Pharmaceuticals
VX-659
VX-445
cystic fibrosis
Flag link:
Vertex cystic fibrosis drug gets expanded approval for use in infants
Vertex cystic fibrosis drug gets expanded approval for use in infants
Reuters
FDA
Vertex Pharmaceuticals
Kalydeco
infants
cystic fibrosis
Flag link:
Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly
Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly
Endpoints
Vertex Pharmaceuticals
NICE
cystic fibrosis
Symkevi
tezacaftor/ivacaftor
Flag link:
Boehringer Ingelheim lands option on cystic fibrosis gene therapy
Boehringer Ingelheim lands option on cystic fibrosis gene therapy
Fierce Biotech
Boehringer Ingelheim
cystic fibrosis
Oxford BioMedica
gene therapy
Flag link:
Pages
1
2
3
4
5
6
7
8
9
next ›
last »